- · 《临床药物治疗杂志》编[10/30]
- · 《临床药物治疗杂志》杂[10/30]
- · 《临床药物治疗杂志》杂[10/30]
- · 《临床药物治疗杂志》期[10/30]
- · 《临床药物治疗杂志》数[10/30]
- · 《临床药物治疗杂志》投[10/30]
- · 临床药物治疗杂志版面费[10/30]
年系统性硬化症和大流行世界硬皮病基金会对患(7)
作者:网站采编关键词:
摘要:[45]PIROLA C J,SOOKOIAN S.Estimation of renin-angiotensinaldosterone-system(RAAS)-inhibitor effect on COVID-19 outcome:a Meta-analysis[J].J Infect,2020,81(2):276-281.DO
[45]PIROLA C J,SOOKOIAN S.Estimation of renin-angiotensinaldosterone-system(RAAS)-inhibitor effect on COVID-19 outcome:a Meta-analysis[J].J Infect,2020,81(2):276-281.DOI:10.1016/.
[46]RUSSELL C D,MILLAR J E,BAILLIE J K.Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J].Lancet,2020,395():473-475.DOI:10.1016/S0140-6736(20)-2.
[47]ZHANG Y,XIAO M,ZHANG S L,et al.Coagulopathy and antiphospholipid antibodies in patients with covid-19[J].N Engl J Med,2020,382(17):e38.DOI:10.1056/NEJMc.
[48]ZHOU F,YU T,DU R H,et al.Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan,China:a retrospective cohort study[J].Lancet,2020,395():1054-1062.DOI:10.1016/S0140-6736(20)-3.
[49]LI T,LU H,ZHANG W.Clinical observation and management of COVID-19 patients[J].Emerg Microbes Infect,2020,9(1):687-690.DOI:10.1080/.2020..
[50]WANG Y,CHEN X D,CAO W,et al.Plasticity of mesenchymal stem cells in immunomodulation:pathological and therapeutic implications[J].Nat Immunol,2014,15(11):1009-1016.DOI:10.1038/ni.3002.
[51]NAJAR M,RAICEVIC G,FAYYAD-KAZAN H,et al.Immune-related antigens,surface molecules and regulatory factors in human-derived mesenchymal stromal cells:the expression and impact of inflammatory priming[J].Stem Cell Rev Rep,2012,8(4):1188-1198.DOI:10.1007/s-012-9408-1.
[52]LENG Z K,ZHU R J,HOU W,et al.Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[J].Aging Dis,2020,11(2):216-228.DOI:10./.
[53]LIU S,PENG D Y,QIU H J,et al.Mesenchymal stem cells as a potential therapy for COVID-19[J].Stem Cell Res Ther,2020,11(1):169.DOI:10.1186/s-020-01678-8.
[54]CHRISTOPEIT M,SCHENDEL M,F?LL J,et al.Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L[J].Leukemia,2008,22(5):1062-1064.DOI:10.1038/sj.leu..
[55]ROJAS M,RODRíGUEZ Y,MONSALVE D M,et al.Convalescent plasma in COVID-19:Possible mechanisms of action[J].Autoimmun Rev,2020,19(7):.DOI:10.1016/.
[56]SAHIN U,MUIK A,DERHOVANESSIAN E,et al.COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses[J].Nature,2020,586(7830):594-599.DOI:10.1038/s-020-2814-7.
[57]XIA S L,DUAN K,ZHANG Y T,et al.Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes:interim analysis of 2 randomized clinical trials[J].JAMA,2020,324(10):951-960.DOI:10.1001/.
[58]WENDLER D,OCHOA J,MILLUM J,et al.COVID-19 vaccine trial ethics once we have efficacious vaccines[J].Science,2020,370(6522):1277-1279.DOI:10.1126/.
[59]NGUYEN T M,ZHANG Y,PANDOLFI P P.Virus against virus:a potential treatment for 2019-nCov(SARS-CoV-2) and other RNA viruses[J].Cell Res,2020,30:189-190.
[60]ABBOTT T R,DHAMDHERE G,LIU Y X,et al.Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza[J].Cell,2020,181(4):.DOI:10.1016/.
刘爱京,主任医师,教授,博士生导师;
E-
文章来源:《临床药物治疗杂志》 网址: http://www.lcywzlzz.cn/qikandaodu/2021/0622/1182.html